Clinical Trial

Nicorandil as Anti-inflammatory in Rheumatoid Arthritis

Study acronym: RA
Recruiting Phase 3
View on ClinicalTrials.gov →
Summary
This study aims to evaluate the possible efficacy and safety of nicorandil as anti-inflammatory in managing patients with active rheumatoid arthritis.
Protocol Amendment History 2 changes
critical Recruitment opened 2026-04-16
critical Primary endpoint(s) modified 2026-04-16
Trial Details
NCT Number NCT07516769
Lead Sponsor Tanta University
Conditions Rhumatoid Arthisis
Enrollment 46 participants
Start Date 2024-11-01
Primary Completion 2027-03 (estimated)
Study Completion 2027-04 (estimated)
Updated on ClinicalTrials.gov 2026-06-18